Literature DB >> 10025604

Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma.

R K Gupta1, U Sinha, T F Cloughesy, J R Alger.   

Abstract

Magnetic resonance spectroscopy and diffusion magnetic resonance imaging (MRI) characteristics of human intracranial glioma were studied. Present knowledge suggests a hypothetical inverse relationship between the characteristic choline signal intensity elevation and the apparent diffusion coefficient (ADC) in glioma. Twenty cases of glioma were examined with diffusion-weighted echoplanar imaging and proton magnetic resonance spectroscopic imaging (1H-MRSI). A statistically significant inverse correlation between the choline signal intensity and the ADC was found (P = 0.0004) in radiologically defined tumor-containing regions. This study is the first in which diffusion MRI and 1H-MRSI were used to evaluate human intracranial glioma jointly. It provides insight into how to interpret choline signal intensity elevation in terms of tumor cellularity and proliferative potential when ADC images are also available.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10025604     DOI: 10.1002/(sici)1522-2594(199901)41:1<2::aid-mrm2>3.0.co;2-y

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  38 in total

1.  Tracking tumor growth rates in patients with malignant gliomas: a test of two algorithms.

Authors:  S M Haney; P M Thompson; T F Cloughesy; J R Alger; A W Toga
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

2.  Brain imaging: the NMR revolution. Interview by Clare Thompson.

Authors:  J W Prichard; J R Alger; R Turner
Journal:  BMJ       Date:  1999-11-13

Review 3.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

4.  Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma.

Authors:  Xintao Hu; Kelvin K Wong; Geoffrey S Young; Lei Guo; Stephen T Wong
Journal:  J Magn Reson Imaging       Date:  2011-02       Impact factor: 4.813

5.  Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy.

Authors:  Su Berrak; Sanjeev Chawla; Sungheon Kim; Harry Quon; Eric Sherman; Laurie A Loevner; Harish Poptani
Journal:  Acad Radiol       Date:  2011-08-10       Impact factor: 3.173

6.  MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas.

Authors:  Chih-Chun Wu; Rajan Jain; Lucidio Neto; Seema Patel; Laila M Poisson; Jonathan Serrano; Victor Ng; Sohil H Patel; Dimitris G Placantonakis; David Zagzag; John Golfinos; Andrew S Chi; Matija Snuderl
Journal:  Neuroradiology       Date:  2019-05-27       Impact factor: 2.804

Review 7.  Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging.

Authors:  Rajan Jain; Jayant Narang; Pia M Sundgren; David Hearshen; Sona Saksena; Jack P Rock; Jorge Gutierrez; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2010-02-24       Impact factor: 4.130

8.  Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Giuseppe M Giannatempo; Teresa Popolizio; Domenico Catapano; Simona Bonavita; Nicola Maggialetti; Michela Tosetti; Ugo Salvolini; Vincenzo A d'Angelo; Giocchino Tedeschi
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

9.  The correlation between 1H MRS choline concentrations and MR diffusion trace values in human brain tumors.

Authors:  Dita Wagnerova; Filip Jiru; Monika Dezortova; Lydie Vargova; Eva Sykova; Milan Hajek
Journal:  MAGMA       Date:  2008-10-25       Impact factor: 2.310

10.  Diffusion imaging for therapy response assessment of brain tumor.

Authors:  Thomas L Chenevert; Brian D Ross
Journal:  Neuroimaging Clin N Am       Date:  2009-11       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.